IRLAB Therapeutics AB (publ) (IRLAB-A) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.00x

IRLAB Therapeutics AB (publ) (IRLAB-A) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr5.26 Million. Explore IRLAB Therapeutics AB (publ) capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

Skr0.00

Capex + Investments

Operating Cash Flow

Skr5.26 Million

SEK

Capital Expenditures

Skr0.00

SEK

IRLAB Therapeutics AB (publ) Cash Flow Reinvestment Rate (2021–2021)

Historical reinvestment intensity for IRLAB Therapeutics AB (publ) across 1 annual periods. Also explore IRLAB-A asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for IRLAB Therapeutics AB (publ) (2021–2021)

Year-by-year capital reinvestment analysis for IRLAB Therapeutics AB (publ). For live market cap and broader valuation context, see IRLAB Therapeutics AB (publ) market cap and net worth.

Year	Reinvestment Rate	Total Reinvested (SEK)	Operating CF	Capex	YoY Change
2021	0.01x	Skr1.42 Million	Skr128.64 Million	Skr708.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow